Share of people with HIV who receive antiretroviral therapy in Cuba
Cuba: Share of people with HIV who receive antiretroviral therapy was 68.0% in 2024. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Cuba, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
In 2024, share of people with hiv who receive antiretroviral therapy in Cuba stood at 68.0%.
The figure is down 1.4% on the previous year and up 54.5% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Cuba peaked at 70.0% in 2022 and was at its lowest, 1.0%, in 2000.
Cuba ranks 82nd of 143 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Cuba, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 1.0% | — |
| 2001 | 6.0% | +500.0% |
| 2002 | 10.0% | +66.7% |
| 2003 | 13.0% | +30.0% |
| 2004 | 14.0% | +7.7% |
| 2005 | 15.0% | +7.1% |
| 2006 | 17.0% | +13.3% |
| 2007 | 19.0% | +11.8% |
| 2008 | 22.0% | +15.8% |
| 2009 | 24.0% | +9.1% |
| 2010 | 27.0% | +12.5% |
| 2011 | 32.0% | +18.5% |
| 2012 | 35.0% | +9.4% |
| 2013 | 38.0% | +8.6% |
| 2014 | 44.0% | +15.8% |
| 2015 | 51.0% | +15.9% |
| 2016 | 55.0% | +7.8% |
| 2017 | 59.0% | +7.3% |
| 2018 | 63.0% | +6.8% |
| 2019 | 68.0% | +7.9% |
| 2020 | 66.0% | -2.9% |
| 2021 | 67.0% | +1.5% |
| 2022 | 70.0% | +4.5% |
| 2023 | 69.0% | -1.4% |
| 2024 | 68.0% | -1.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 14.1% | 1.0% | 24.0% | 10 |
| 2010s | 47.2% | 27.0% | 68.0% | 10 |
| 2020s | 68.0% | 66.0% | 70.0% | 5 |
Countries ranked near Cuba
More health data for Cuba
- Un projection of annual infant deaths, annual growth rate -1.47 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2059 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,696 deaths per 1,000 people (2090)
- Number of infants who die before age 1 67 deaths (2100)
- Population ages 75-79, female, annual growth rate 1.27 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2020)
- Population ages 75-79, female, per capita 0.0187 units per person (2025)
- Population ages 75-79, male, annual growth rate 1.42 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2020)
- Population ages 75-79, male, per capita 0.0148 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Cuba?
- Share of people with hiv who receive antiretroviral therapy in Cuba was 68.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Cuba?
- The highest recorded value was 70.0% in 2022.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Cuba?
- The lowest recorded value was 1.0% in 2000.
- How does Cuba rank for share of people with hiv who receive antiretroviral therapy?
- Cuba ranks 82nd out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Cuba?
- Over the last ten years it is up 54.5%. The long-run trend across the full record is volatile.
- Where does this Cuba data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.